A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a California resident who died of a rare form of cancer. The family filed a suit against the company claiming that its baby powder contains a carcinogen. Mae Moore died in 2021 from mesothelioma, cancer of the mesothelium –…
Johnson & Johnson pharma rebrand highlights innovation as a pillar to reinforce trust
Global pharma and medical device giant Johnson & Johnson (J&J) has ditched its iconic cursive logo that dates back to the late 19th century, and rebranded its Janssen pharma division as Johnson & Johnson Innovative Medicine. The move underscores the company’s push to prioritize higher-margin prescription drugs. This strategic move comes amidst a backdrop of…